On Tuesday, Shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), gained 0.26% to $3.90.
AcelRx Pharmaceuticals, declared that the European Commission (EC) has approved Zalviso (15 micrograms sufentanil sublingual tablets) for the administration of acute moderate-to-severe post-operative pain in adult patients. The marketing authorization is granted for the 28 EU member states in addition to for the European Economic Area (EEA) countries, Norway, Iceland and Liechtenstein. Zalviso is a system combining a drug and a device designed to deliver a sublingual tablet formulation of sufentanil 15 mcg via a proprietary, pre-programmed, non-invasive, patient-controlled analgesia (PCA) device. Grunenthal Group, AcelRx’s licensee in Europe and Australia, anticipates the product to be available to Western European patients in the first half of 2016.
On an annual basis, there are 19 million surgical procedures with associated acute moderate-to-severe post-operative pain in the European Union. A recent German survey in patients after surgery has shown that 55% of all patients are not satisfied with their treatment for post-operative pain1. Even more so, 30% mention that their pain administration has been inadequately effective [1 Maier C et al. Dtsch Arztebl Int. 2010; 107; 607-614].
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. The companys lead product candidate is Zalviso, an investigational, pre-programmed, non-invasive, handheld system that has accomplished Phase III clinical trials for the treatment of moderate-to-severe acute pain in the hospital setting.
Shares of Jack in the Box Inc. (NASDAQ:JACK), inclined 4.36% to $78.28, during its last trading session.
Jack in the Box Inc., declared that its Board of Directors has authorized an additional $200 million stock buyback program commencing in fiscal year 2016 and expiring in November 2017.
During fiscal year 2015, the company repurchased about 3,743,000 shares at an average price of $84.71 per share, for an aggregate cost of $317.1 million, counting $65.5 million in the fourth quarter of fiscal 2015. This accomplished a $100 million stock buyback program authorized by the company’s Board of Directors in May 2015.
Jack in the Box Inc. operates and franchises Jack in the Box quick-service restaurants and Qdoba Mexican Grill fast-casual restaurants in the United States. As of February 17, 2015, it operated about 2,200 restaurants in 21 states and Guam; and operated and franchised 600 Qdoba Mexican Grill restaurants in 47 states, the District of Columbia, and Canada. The company was founded in 1951 and is based in San Diego, California.
At the end of Tuesday’s trade, Shares of St. Jude Medical, Inc. (NYSE:STJ), lost -0.55% to $66.60.
St. Jude Medical, declared CE Mark approval for the St. Jude Medical Infinity Deep Brain Stimulation (DBS) System and directional DBS lead. The St. Jude Medical Infinity DBS system, which will be available in two sizes, is the only upgradeable DBS system available to patients battling movement disorders. The system uses Bluetooth wireless technology to communicate between the St. Jude Medical Infinity DBS platform and Apple digital devices used as patient and physician controllers. Combined, the features of the system provide an improved, more intuitive experience for patients suffering from Parkinson’s disease, tremor and dystonia, a disorder which causes involuntary muscle contractions.
Movement disorders are neurologic conditions that develop as communications breakdown throughout a patient’s central nervous system, leading to a debilitating lack of muscle control, involuntary movement, and reduced coordination. With no proven cure, treatments for movement disorders often focus on alleviating the symptoms associated with each condition to improve quality of life. Combined, Parkinson’s disease, dystonia and tremor represent the three most common movement disorders in the world.
DBS systems deliver mild electrical pulses to specific targets in the brain to stimulate the structures involved in motor control. The systems comprise of a surgically-implanted neurostimulator that generates the electrical pulses and thin wires called leads which carry the pulses to the brain to influence the irregular nerve signals responsible for many of the symptoms of movement disorders.
St. Jude Medical, Inc., together with its auxiliaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm administration, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies.
Finally, Memorial Production Partners LP (NASDAQ:MEMP), ended its last trade with -4.32% loss, and closed at $5.54.
Alerian declared that following the close of business on Friday, September 18, Boardwalk Pipeline Partners LP (BWP), Columbia Pipeline Partners LP (CPPL), and Vanguard Natural Resources LLC (VNR) will be added to the Alerian MLP Index (AMZ) and the Alerian MLP Equal Weight Index (CME:AMZE).
Boardwalk Pipeline Partners provides transportation, storage, gathering and processing of natural gas and liquids. Columbia Pipeline Partners owns, operates, and develops natural gas pipelines, storage, and related midstream assets. Vanguard Natural Resources focuses on the acquisition, production, and development of oil and natural gas properties.
Hi-Crush Partners LP (HCLP), Linn Energy LLC (LINE), and Memorial Production Partners LP (MEMP) will be removed from the two indices following the close of business on September 18.
The 50 constituents of the Alerian MLP Index will be rebalanced on a float-adjusted, capitalization-weighted basis in accordance with the existing index methodology. The 50 constituents of the Alerian MLP Equal Weight Index will be rebalanced on an equal-weighted basis in accordance with the existing index methodology. Constituent additions to and deletions from the index do not reflect an opinion by Alerian on the investment merits of the respective securities.
Memorial Production Partners LP, through its partner, engages in the acquisition, development, exploitation, and production of oil and natural gas properties. Its properties comprise of operated and non-operated working interests in producing and undeveloped leasehold acreage, and working interests in identified producing wells located in Texas, Louisiana, Colorado, Wyoming, New Mexico, and offshore Southern California.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.